Results for tag: "Biosuperior"

The Biosuperior market is a subset of the Biosimilar market, which focuses on the development of biologic drugs that are similar to existing biologic drugs. Biosuperiors are biologic drugs that are developed to be more effective than existing biologic drugs, and are often developed to be more cost-effective. Biosuperiors are developed using a variety of techniques, such as improving the manufacturing process, altering the drug's structure, or using different delivery methods. Biosuperiors are typically developed to treat the same conditions as existing biologic drugs, but may also be developed to treat new conditions. Some companies in the Biosuperior market include Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, and Mylan. Show Less Read more